Anaconda Biomed said it raised nearly $17 million (€15 million) in a Series A round for the neurothrombectomy device it’s developing. The round, led by new investors Ysios Capital, Omega Funds and Banco Sabadell and prior backer Innogest Capital, is enough to carry the ANCD Brain device through validation & verification and clinical studies ahead of a CE Mark […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Stem cells and graphene can regenerate nerves: Here’s how
Iowa State University researchers have developed a nanotechnology that turns mesenchymal stem cells into Schwann cells for nerve regeneration. Schwann cells form sheaths around axons on nerves and promote regeneration of axons. They also produce substances that help promote the health of nerve cells. Both actions are helpful for researchers who are looking to regenerate […]
Neurotrack raises $10m
Cognitive decline tracking company Neurotrack has raised $9.9 million in a new round of equity financing, according to an SEC filing posted this week. Palo Alto, Calif.-based Neurotrack’s 1st product is the Imprint, a digital cognitive assessment test designed to track cognitive decline and help advance research and treatment of cognitive diseases like Alzheimers. The […]
Integra LifeSciences, Johnson & Johnson pass papers on $1B Codman Neuro buy
Integra LifeSciences (NSDQ:IART) said yesterday that it passed papers with Johnson & Johnson (NYSE:JNJ) last week on its $1.05 billion cash bid for J&J’s Codman Neurosurgery unit. Completing the deal still hinges on the expiration of the Hart-Scott-Rodino waiting period and antitrust approvals in Spain and the U.K., Integra said in a regulatory filing. When it announced the deal […]
Nobilis, Submersible Systems to develop hand-held inhalation device for neurological drugs
Nobilis Therapeutics said today that it partnered with device manufacturer Submersible Systems to develop a portable, hand-held inhalation device that administers a xenon gas-based therapeutic, NBTX-001. The companies said they are working on customizing and testing the drug-device combination. The group plans to pursue regulatory approval with the FDA, supported by upcoming clinical trials in […]
Patients with Parkinson’s disease help to shape clinical trial design
Margaret Sheehan isn’t a scientist, but she is 1 of many patient scientists joining an effort to incorporate Parkinson’s patients’ preference into the design of clinical trials for new treatments. Sheehan, a Virginia-based lawyer, has had Parkinson’s disease since 2004. She told Drug Delivery Business News that when the folks at the Medical Device Innovation Consortium presented last spring […]
Insightec wins FDA nod for Exablate Neuro for use with 1.5T MRI
Insightec said today it won FDA approval for its Exablate Neuro model 4000 system, now cleared for use with 1.5 Tesla magnetic resonance imaging for treating essential tumor in patients non-responsive to medication. The Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed […]
MagVenture wins FDA nod for entry-level MagVita TMS device
Non-invasive magnetic stimulation developer MagVenture said today it won FDA clearance for an entry-level version of its MagVita transcranial magnetic stimulation device designed for treating major depressive disorder. The Atlanta-based company said that the newly cleared device is designed specifically for smaller psychiatric practices looking to begin to provide TMS services but are unsure of […]
Antidepressant could help ferry drugs across blood-brain barrier
Researchers at the National Institutes of Health have found that pairing an antidepressant with neurological drugs can enhance drug delivery to the brain. The team’s research was published online in the Journal of Cerebral Blood Flow and Metabolism. Although consuming a lot of drugs can get you an overdose, drug addiction and substance abuse is becoming […]
Midazolam nasal spray trial meets primary endpoint in patients with seizure clusters
Proximagen Ltd. said today that its pivotal Phase III trial of intranasal midazolam met its primary efficacy endpoint as a treatment for patients with seizure clusters. The Cambridge-based company said it plans to begin talks with the FDA for a New Drug Application in the 2nd half of this year based on the trial’s findings. […]
Acorda misses on Q1 earnings, slashes expense guidance after restructuring
Shares in Acorda Therapeutics (NSDQ:ACOR) fell today after the biopharmaceutical company missed expectations on Wall Street with its 1st quarter results. The Ardsley, N.Y.-based company posted a net loss of -$18.9 million, or -41¢ per share, on sales of $119.4 million for the 3 months ended March 31. In the same quarter last year, Acorda reported […]